BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15131764)

  • 21. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice.
    Hundertmark S; Dill A; Ebert A; Zimmermann B; Kotelevtsev YV; Mullins JJ; Seckl JR
    Horm Metab Res; 2002 Oct; 34(10):545-9. PubMed ID: 12439781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.
    Jamieson PM; Nyirenda MJ; Walker BR; Chapman KE; Seckl JR
    J Endocrinol; 1999 Jan; 160(1):103-9. PubMed ID: 9854182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues.
    Morris DJ; Souness GW; Latif SA; Hardy MP; Brem AS
    Metabolism; 2004 Jun; 53(6):811-6. PubMed ID: 15164334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
    Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11Beta-hydroxysteroid dehydrogenase in the Dahl rat.
    Franco-Saenz R; Tokita Y; Latif S; Morris DJ
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):1004-9. PubMed ID: 9324106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.
    Whorwood CB; Sheppard MC; Stewart PM
    Endocrinology; 1993 Jun; 132(6):2287-92. PubMed ID: 8504732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker rats.
    Al-Barazanji KA; Buckingham RE; Arch JR; Briscoe C; Jenkins O; Tadayyon M
    Diabetes Obes Metab; 2001 Dec; 3(6):435-42. PubMed ID: 11903416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
    Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
    Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
    Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feeding Obese Diabetic Mice a Genistein Diet Induces Thermogenic and Metabolic Change.
    Rockwood S; Broderick TL; Al-Nakkash L
    J Med Food; 2018 Apr; 21(4):332-339. PubMed ID: 29261006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity.
    Schweizer RA; Atanasov AG; Frey BM; Odermatt A
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):41-9. PubMed ID: 14654249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
    Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
    Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats.
    Cettour-Rose P; Rohner-Jeanrenaud F
    Endocrinology; 2002 Jun; 143(6):2277-83. PubMed ID: 12021192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 in the kidneys of insulin-dependent diabetic rats.
    Liu YJ; Nakagawa Y; Ohzeki T
    Hypertension; 1998 Mar; 31(3):885-9. PubMed ID: 9495277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute anti-obesity effects of intracerebroventricular 11β-HSD1 inhibitor administration in diet-induced obese mice.
    Seo M; Islam SA; Moon SS
    J Neuroendocrinol; 2018 Mar; 30(3):e12580. PubMed ID: 29418022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responses of lean and obese Zucker rats to centrally administered leptin.
    Wang T; Hartzell DL; Flatt WP; Martin RJ; Baile CA
    Physiol Behav; 1998 Nov; 65(2):333-41. PubMed ID: 9855484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.